These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2784323

  • 1. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrow.
    Preijers FW, De Witte T, Wessels JM, Meyerink JP, Haanen C, Capel PJ.
    Br J Haematol; 1989 Feb; 71(2):195-201. PubMed ID: 2784323
    [Abstract] [Full Text] [Related]

  • 2. Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma.
    Preijers FW, De Witte T, Wessels JM, De Gast GC, Van Leeuwen E, Capel PJ, Haanen C.
    Blood; 1989 Aug 15; 74(3):1152-8. PubMed ID: 2473811
    [Abstract] [Full Text] [Related]

  • 3. Different susceptibilities of normal T cells and T cell lines to immunotoxins.
    Preijers FW, Tax WJ, Wessels JM, Capel PJ, De Witte T, Haanen C.
    Scand J Immunol; 1988 May 15; 27(5):533-40. PubMed ID: 3259720
    [Abstract] [Full Text] [Related]

  • 4. Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins.
    Preijers FW, Tax WJ, De Witte T, Janssen A, vd Heijden H, Vidal H, Wessels JM, Capel PJ.
    Br J Haematol; 1988 Nov 15; 70(3):289-94. PubMed ID: 3264717
    [Abstract] [Full Text] [Related]

  • 5. Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity.
    Preijers FW, De Witte T, Rijke-Schilder GP, Tax WJ, Wessels JM, Haanen C, Capel PJ.
    Scand J Immunol; 1988 Aug 15; 28(2):185-94. PubMed ID: 3261884
    [Abstract] [Full Text] [Related]

  • 6. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
    Montgomery RB, Kurtzberg J, Rhinehardt-Clark A, Haleen A, Ramakrishnan S, Olsen GA, Peters WP, Smith CA, Haynes BF, Houston LL.
    Bone Marrow Transplant; 1990 Jun 15; 5(6):395-402. PubMed ID: 2369680
    [Abstract] [Full Text] [Related]

  • 7. An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A.
    Myers CD, Thorpe PE, Ross WC, Cumber AJ, Katz FE, Tax W, Greaves MF.
    Blood; 1984 May 15; 63(5):1178-85. PubMed ID: 6370334
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxicity of CD3-ricin A chain immunotoxins in relation to cellular uptake and degradation kinetics.
    van Oosterhout YV, Preijers FW, Wessels HM, de Witte T.
    Cancer Res; 1992 Nov 01; 52(21):5921-5. PubMed ID: 1394218
    [Abstract] [Full Text] [Related]

  • 9. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
    Uckun FM, Myers DE, Ledbetter JA, Swaim SE, Gajl-Peczalska KJ, Vallera DA.
    J Immunol; 1988 Mar 15; 140(6):2103-11. PubMed ID: 3126241
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
    Jansen B, Vallera DA, Jaszcz WB, Nguyen D, Kersey JH.
    Cancer Res; 1992 Mar 01; 52(5):1314-21. PubMed ID: 1371092
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
    Fishwild DM, Aberle S, Bernhard SL, Kung AH.
    Cancer Res; 1992 Jun 01; 52(11):3056-62. PubMed ID: 1375534
    [Abstract] [Full Text] [Related]

  • 12. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S, Villa S, Bonadonna G, Bregni M, Gianni AM.
    Transplantation; 1987 Mar 01; 43(3):421-6. PubMed ID: 3103275
    [Abstract] [Full Text] [Related]

  • 13. Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation.
    Leonard JE, Taetle R, To D, Rhyner K.
    Blood; 1985 May 01; 65(5):1149-57. PubMed ID: 3888307
    [Abstract] [Full Text] [Related]

  • 14. An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys.
    Hertler AA, Schlossman DM, Borowitz MJ, Poplack DG, Frankel AE.
    Cancer Immunol Immunother; 1989 May 01; 28(1):59-66. PubMed ID: 2783301
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen.
    Wu M, Tang SL, Zang RJ, Yu H.
    Int J Immunopharmacol; 1990 May 01; 12(2):235-9. PubMed ID: 2329015
    [Abstract] [Full Text] [Related]

  • 18. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
    Wawrzynczak EJ, Watson GJ, Cumber AJ, Henry RV, Parnell GD, Rieber EP, Thorpe PE.
    Cancer Immunol Immunother; 1991 May 01; 32(5):289-95. PubMed ID: 1998970
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC.
    Cancer Res; 1986 Mar 01; 46(3):1208-13. PubMed ID: 3510720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.